Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 14 · below the Ichimoku cloud · RSI 25 (oversold) · MACD above its signal
| 1.69 | 52-week high | +2504.01% |
| 0.1790 | Previous month high | +175.81% |
| 0.0930 | Previous week high | +43.30% |
| 0.0810 | Previous month low | +24.81% |
| 0.0768 | R3 (classic) | +18.28% |
| 0.0724 | R2 (classic) | +11.61% |
| 0.0687 | R1 (classic) | +5.80% |
| 0.0681 | Previous day high | +4.93% |
| 0.0649 | Price now | |
| 0.0643 | Pivot | −0.87% |
| 0.0606 | S1 (classic) | −6.68% |
| 0.0600 | Previous day low | −7.55% |
| 0.0562 | S2 (classic) | −13.35% |
| 0.0525 | S3 (classic) | −19.16% |
| 0.0520 | Previous week low | −19.88% |
| 0.0520 | 52-week low | −19.88% |
None of the 29 investors followed here reported a position in ADGM in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ADGM trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.8 | 0.0 | 15.0 | -21.7 | -19.6 | -9.9 | -42.0 | 39.7 | -71.0 | -45.8 | -21.8 | −93.8% | |
| 2025 | 11.4 | -28.8 | -3.4 | 60.2 | -12.4 | 15.0 | 1.5 | 22.0 | 20.5 | -41.2 | -29.6 | 29.7 | −1.0% |
| 2024 | -49.9 | 4.7 | -1.1 | -60.7 | −79.6% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 15, 2025 | Kaster DeborahChief Financial Officer | Purchase at price 1.20 per share. | 15K | $17.97K |
| Dec 11, 2025 | Usen ToddChief Executive Officer | Purchase at price 1.09 per share. | 207.3K | $225.97K |
| Jan 21, 2025 | Perceptive Advisors, L.L.C.Unknown | Stock Award(Grant) at price 0.00 per share. | 64.2K | — |
TimeframesDown on all 3 timeframes: no timeframe is holding up.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
Buy / hold / sell counts
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.